NCT06436885 2024-05-31An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung CancerHenan Cancer HospitalPhase EARLY_PHASE1 Recruiting39 enrolled